Collection of Autologous Blood Products by Double Erythrocytapheresis
NCT ID: NCT00202475
Last Updated: 2009-10-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
100 participants
INTERVENTIONAL
2003-09-30
2007-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison Between Return and Wastage of Your Own Blood, Collected During Spinal Surgery, for Verification of Safety When Returning Blood
NCT01251042
High Yield Intraoperative, Autologous Platelet Apheresis
NCT01819246
Blood Salvage From Liver Donors: a Feasibility Pilot Study
NCT05835882
Comparison in Need for Bank Blood Between Patients Undergoing Total Hip Surgery That Either Receive Their Own Blood Back or Not
NCT00822588
Data Collection of Routine Clinical Use With the Spectra Optia® Apheresis System for White Blood Cell Depletion
NCT02302365
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
eythrocytapheresis
machinal collection of erythrocytes
2
whole blood collection
collection of whole blood
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
eythrocytapheresis
machinal collection of erythrocytes
whole blood collection
collection of whole blood
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Severe arrhythmias
* Congestive heart failure
* Recent angina
* Epileptic seizures in the last 3 months before collection
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Atrium Medical Center
OTHER
Maasland Hospital
OTHER
Sanquin Research & Blood Bank Divisions
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sanquin Blood BankDivision South-east
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eva Rombout, MD
Role: PRINCIPAL_INVESTIGATOR
Sanquin Research and Blood Bank Divisions
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sanquin Bloodbank
Maastricht, Limburg, Netherlands
Sanquin Blood Bank Southeast Region
Maastricht, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PPO-C-02-15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.